Melatonin-Mepha 2 mg, Retardtabletten - 100 Swissmedic Key 68681002 Registration Holder Mepha Pharma AG Name Melatonin-Mepha 2 mg, Retardtabletten Date of registration 11.08.2022 Introduction of Sequence 11.08.2022 ATC-Classification Melatonin (N05CH01) Revision date WHO WHO-DDD Valid until 10.08.2027 Index Therapeuticus (BSV) Show package size 100 Index Therapeuticus (Swissmedic) 01.03.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680686810020 Medication Code Synthetika Pharmacode Disponibility
Composition melatoninum 2 mg, ammonio methacrylatis copolymerum B, calcii hydrogenophosphas dihydricus, talcum, lactosum monohydricum 80 mg, magnesii stearas, silica colloidalis anhydrica, pro compresso obducto. Packungsbestandteile Galenic Form Delayed release tablets Inactive agents Dose Calcium Hydrogen Phosphate Dihydrate Lactose Monohydrate 80 mg Silica Colloidalis Anhydrica Talcum
Source Data was imported : 02.09.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
